Subchronic inhalation and oral toxicity of N-vinylpyrrolidone-2. Studies in rodents.
N-Vinylpyrrolidone-2 (NVP) is a monomeric compound used as an industrial intermediate. Nine of 11 studies previously reported involved exposure of rats (two different strains), mice or hamsters to NVP by the inhalation route at concentrations of up to 120 ppm (6 hr/day, 5 days/wk) over a period of 1 wk to 12 months. The remaining two studies involved exposure of rats to NVP through the drinking water or by gavage at dose levels of up to 100 mg/kg body weight/day. Reduced body weight gain was seen in rats exposed by inhalation to 5 ppm or more for 3 months and in mice and hamsters exposed to 45 ppm for only 1 day. Effects were seen on haematological (reduced haemoglobin, erythrocyte count, haematocrit) and clinical chemistry parameters (specially raised gamma-glutamyltransferase activity and decreases in plasma protein), liver weight increase and liver lesions (centrilobular single-cell necrosis and foci of hepatocellular alteration) in rats and mice but not hamsters. Rats exposed to 40 mg/kg body weight/day NVP or more for 3 months by gavage developed similar liver changes. Atrophy of olfactory epithelium and hyperplasia of nasal respiratory epithelium was seen in rats exposed by inhalation to 5 ppm NVP for 7 wk but not in response to 1 ppm for 13 wk (no observed-adverse-effect level, NOAEL). These studies indicated that the upper respiratory tract and the liver are the main targets for NVP toxicity.
Klimisch
H J
HJ
BASF Aktiengesellschaft, Department of Toxicology, Ludwigshafen, Germany.
Deckardt
K
K
Gembardt
C
C
Hildebrand
B
B
Küttler
K
K
Roe
F J
FJ
D000280:Administration, Inhalation; D000284:Administration, Oral; D000818:Animals; D001672:Biocompatible Materials / Q000633:toxicity*; D001772:Blood Cell Count / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D019963:Clinical Chemistry Tests; D006224:Cricetinae; D005260:Female; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D051379:Mice; D009296:Nasal Cavity / Q000187:drug effects / Q000473:pathology; D009929:Organ Size / Q000187:drug effects; D011760:Pyrrolidinones / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley
D001672:Biocompatible Materials; D011760:Pyrrolidinones; C042670:N-vinyl-2-pyrrolidinone